DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)

16.90 -0.09 (-0.53%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AVNR $16.90 -0.53%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.94
Previous Close $16.99
Daily Range $16.85 - $16.98
52-Week Range $2.65 - $17.05
Market Cap $3.3B
P/E Ratio -54.81
Dividend (Yield) $0.00 (0.0%)
Volume 13,890,537
Average Daily Volume 7,826,650
Current FY EPS -$0.21

Sector

Healthcare

Industry

Drugs

AVANIR PHARMACEUTICALS (AVNR) Description

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Website: http://www.avanir.com/

News & Commentary Rss Feed

3 Traits of the Best Healthcare Stocks in 2014

The best healthcare stocks in 2014 saw their shares gain as much as 400% because they exhibited at least one of the following three key traits.

Pre-Market Most Active for Dec 19, 2014 : ALLY, BBRY, BP, AVNR, TNK, PBR, OREX, BHP, SDRL, QQQ, AAP

Pre-Market Most Active for Dec 19, 2014 : ALLY, BBRY, BP, AVNR, TNK, PBR, OREX, BHP, SDRL, QQQ, AAPL, IMGN

After-Hours Earnings Report for December 10, 2014 : RH, AVNR, CASY, MW, OXM, IRET, CMTL, PPHM, SIGM

After-Hours Earnings Report for December 10, 2014 : RH, AVNR, CASY, MW, OXM, IRET, CMTL, PPHM, SIGM, SURG, CENT, AVNW

Merger Arbitrage Mondays - December 8, 2014

Avanir to be acquired by Otsuka for $3.5 Billion, Shares Up - Analyst Blog

UPDATE: Deutsche Bank Downgrades Avanir Pharmaceuticals, $17 Buyout Target 'Fair'

Avanir Pharmaceuticals, Inc. (AVNR) in Focus: Stock Soars 12.8% - Tale of the Tape

Jim Cramer on the Stock Market: You Have to Love Biotech

Benzinga's M&A Chatter for Tuesday December 2, 2014

Energy Stocks Shake Off Plunging Oil Prices to Push the Dow to New Highs

See More AVNR News...

AVNR's Top Competitors

AVNR $16.90 (-0.53%)
Current stock: AVNR
JNJ $105.55 (-1.18%)
Current stock: JNJ
PFE $31.94 (-0.09%)
Current stock: PFE
NVS $94.61 (0.04%)
Current stock: NVS